| Literature DB >> 32866519 |
Senko Tsukuda1, Koichi Watashi2.
Abstract
Hepatitis B virus (HBV) specifically infects hepatocytes and causes severe liver diseases. The HBV life cycle is unique in that the genomic DNA (relaxed-circular partially double-stranded DNA: rcDNA) is converted to a molecular template DNA (covalently closed circular DNA: cccDNA) to amplify a viral RNA intermediate, which is then reverse-transcribed back to viral DNA. The highly stable characteristics of cccDNA result in chronic infection and a poor rate of cure. This complex life cycle of HBV offers a variety of targets to develop antiviral agents. We provide here an update on the current knowledge of HBV biology and its life cycle, which may help to identify new antiviral targets.Entities:
Keywords: Entry; HBV; Life cycle; NTCP; Replication; cccDNA
Mesh:
Substances:
Year: 2020 PMID: 32866519 DOI: 10.1016/j.antiviral.2020.104925
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970